To: data_rox who wrote (91106 ) 4/23/2010 9:48:24 PM From: Jim Mullens 1 Recommendation Respond to of 197227 DR, re: good data from Morgan Stanley #2- Something more to think about for the QCOM slow growthers-- During the CC Q&A, Arnab Chanda - Roth Capital asked about new QCT Products / Incremental Revenue streams Steve M gave a low key response re: WiFi (Bluetooth / Femto cells) --- (per SeakingAlpha’s translation)—It’s being sold today as a stand-alone devise in very small quantities. It will eventually become a feature that goes into our smart phones product portfolio” WiFi Chips I’ve posted on this before, but this time using Morgan Stanley’s WiFi device projections- ……………………………………2009…….2013 Bluetooth chips……… …..….…387M……1,039M (smartphones only -87M , 526M) QCOM % share……………………0%.........25% QCOM units…………………………………..260M ASP……………………………………………$4 Revenue………………………………......$1,040MBluetooth chips (I never posted on bluetooth chip potential revenue) ……………………………………2009…….2013 Bluetooth chips- …..….…………1.5B……..2.5B QCOM % share……………………0%.........25% QCOM units………………………10M?……625M ASP……………………………………………..$2 Revenue………………………………......$1,250M A billion here, a billion there / it starts to add up! >>>>>>>>>>>> Arnab Chanda - Roth Capital Thank you. Can you talk a little bit about your QCT business kind of qualitatively. When do you expect to see revenues from some of the non-cellular technology that you are looking at. Like thicker cells or things like Wi-Fi or other wireless technologies. Derek Aberle ( Steve M) On the first question about QCT and some of the non-traditional products I will call them, they probably fall in a phases, because right now we are shipping bluetooth in the tens of millions of units a year. It’s a growing business that we have lowered ASP obviously than the core MSM business, but they are progressing well. WiFi is behind. It’s being sold today as a stand-alone devise in very small quantities. It will eventually become a feature that goes into our smart phones product portfolio. And then on the femto cell side we are really in the process now of first engineering samples this year. We won’t see revenue on that for at least twelve months from now.